瀏覽海報時間

MP03-01: Treatment strategy for dialysis patient with urothelial carcinoma

MP03-02: The pan-immune-inflammation value is a new prognostic biomarker in upper tract urothelial carcinoma

MP03-03: New treatment strategies for overcoming the chemoresistance of urothelial carcinoma

MP03-04: Cost-effectiveness analysis of immune checkpoint inhibitors in metastatic urothelial cancer, a single-center retrospective study

MP03-05: Aquaporins are involved in tumor formation and may potentially act as a therapeutic target in urothelial carcinoma

MP03-06: Effects of variant histology on the oncology outcomes of patients with upper tract urothelial carcinoma after radical nephroureterectomy

MP03-07: The role of lymph node dissection in patients with upper tract urothelial carcinoma without clinical lymph node metastasis undergoing radical nephroureterectomy

MP03-08: Blockade of the autophagic flux suppresses antitumor immunity via programmed death ligand-1 up-regulation in bladder cancer

MP03-09: Second primary malignancy risk in patients with upper urinary tract urothelial carcinoma in Taiwan - a nationwide population-based study

MP03-10: Establishing predictive model of renal function after unilateral nephroureterectomy in upper tract urothelial carcinoma patients